Cash on Hand as of September 2024 : โฌ4.01 Million
According to BioNexus Gene Lab's latest financial reports the company has โฌ4.01 Million in cash and cash equivalents. A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
BioNexus Gene Lab - Cash on Hand chart (from 2019 to 2024)